中华胸心血管外科杂志
中華胸心血管外科雜誌
중화흉심혈관외과잡지
Chinese Journal of Thoracic and Cardiovascular Surgery
2009年
6期
402-405
,共4页
施梦%王宜青%庞烈文%黄杰春%曹同瓦%白春学
施夢%王宜青%龐烈文%黃傑春%曹同瓦%白春學
시몽%왕의청%방렬문%황걸춘%조동와%백춘학
呼吸窘迫综合征%成人%地塞米松%依达拉奉
呼吸窘迫綜閤徵%成人%地塞米鬆%依達拉奉
호흡군박종합정%성인%지새미송%의체랍봉
Respiratory distress syndrome,adult%Dexamethasone%Edaravone
目的 探讨依达拉奉(EDA)和地塞米松(DXM)对脓毒症大鼠肺损伤的干预作用.方法 50只SD大鼠随机分为假手术组(sham组)、手术对照组(CLP组)、依达拉奉治疗组(EDA组)、地塞米松治疗组(DXM组)和依达拉奉联合地塞米松治疗组(E+D组).采用盲肠结扎穿刺法造脓毒血症大鼠肺损伤模型,药物治疗组造模后立即经阴茎背静脉注射EDA(5mg/kg),DXM(5mg/kg)或EDA(5mg/kg)+DXM(5mg/kg);另两组均以等量生理盐水代替.结果 与 sham组相比,CLP组大鼠病理评分,肺干湿重比(W/D),肺泡通透指数(LPI),肺组织中MPO,MDA,IL-6,TNF-α,肺组织中凋亡细胞数量明显增加,而肺组织中T-AOC活性明显减轻.应用地塞米松,依达拉奉药物干预后,上述指标均有不同程度的改善.两种药物联合应用与单个药物应用相比,这些指标有更明显的改善.结论 依达拉奉预处理对脓毒症诱导的肺损伤有明显的防治效果,减轻急性肺损伤的机制可能是通过减少氧自由基产物,减少炎性细胞因子浓度.依达拉奉和地塞米松联合应用对肺损伤有更好的治疗效果.
目的 探討依達拉奉(EDA)和地塞米鬆(DXM)對膿毒癥大鼠肺損傷的榦預作用.方法 50隻SD大鼠隨機分為假手術組(sham組)、手術對照組(CLP組)、依達拉奉治療組(EDA組)、地塞米鬆治療組(DXM組)和依達拉奉聯閤地塞米鬆治療組(E+D組).採用盲腸結扎穿刺法造膿毒血癥大鼠肺損傷模型,藥物治療組造模後立即經陰莖揹靜脈註射EDA(5mg/kg),DXM(5mg/kg)或EDA(5mg/kg)+DXM(5mg/kg);另兩組均以等量生理鹽水代替.結果 與 sham組相比,CLP組大鼠病理評分,肺榦濕重比(W/D),肺泡通透指數(LPI),肺組織中MPO,MDA,IL-6,TNF-α,肺組織中凋亡細胞數量明顯增加,而肺組織中T-AOC活性明顯減輕.應用地塞米鬆,依達拉奉藥物榦預後,上述指標均有不同程度的改善.兩種藥物聯閤應用與單箇藥物應用相比,這些指標有更明顯的改善.結論 依達拉奉預處理對膿毒癥誘導的肺損傷有明顯的防治效果,減輕急性肺損傷的機製可能是通過減少氧自由基產物,減少炎性細胞因子濃度.依達拉奉和地塞米鬆聯閤應用對肺損傷有更好的治療效果.
목적 탐토의체랍봉(EDA)화지새미송(DXM)대농독증대서폐손상적간예작용.방법 50지SD대서수궤분위가수술조(sham조)、수술대조조(CLP조)、의체랍봉치료조(EDA조)、지새미송치료조(DXM조)화의체랍봉연합지새미송치료조(E+D조).채용맹장결찰천자법조농독혈증대서폐손상모형,약물치료조조모후립즉경음경배정맥주사EDA(5mg/kg),DXM(5mg/kg)혹EDA(5mg/kg)+DXM(5mg/kg);령량조균이등량생리염수대체.결과 여 sham조상비,CLP조대서병리평분,폐간습중비(W/D),폐포통투지수(LPI),폐조직중MPO,MDA,IL-6,TNF-α,폐조직중조망세포수량명현증가,이폐조직중T-AOC활성명현감경.응용지새미송,의체랍봉약물간예후,상술지표균유불동정도적개선.량충약물연합응용여단개약물응용상비,저사지표유경명현적개선.결론 의체랍봉예처리대농독증유도적폐손상유명현적방치효과,감경급성폐손상적궤제가능시통과감소양자유기산물,감소염성세포인자농도.의체랍봉화지새미송연합응용대폐손상유경호적치료효과.
Objective Based on the known properties of edaravone(EDA) and dexamethasone (DXM) to inhibit inflammation and oxidative stress,the present study was designed to investigate potential effects of EDA and DXM on acute lung injury induced by cecum ligation and puncture (CLP) in rats. Methods Acute lung injury following sepsis was reproduced by cecum ligation and puncture (CLP) in fifty male Sprague-Dawley(SD) rats. The experiments were randomized into 5 groups (each group n = 10):sham group,CLP group, edaravone group( EDA group, EDA 5 mg/kg), dexamethasone group( DXM group, DXM S mg/kg), edaravone and dexamethasone group(E + D group, EDA S mg/kg + DXM 5 mg/kg) EDA or/and DXM was administrated after CLP via single vena dorsalis penis injection. Other two groups were given the same volume of saline following CLP. Results In vivo,acute lung injury resulted from sepsis was characterized by an increase in lung injury score, lung microvascular permeability, serum malondialdehyde ( MDA) and the level of myeloperoxidase( MPO) activity, tumor necrosis factor-a, interleukin-6 and MDA in the lung tissue, accompanied with a decrease in total anti-oxidative capability (T-AOC) in the serum and lung tissue ampared with the sham group,the above biomarkers were improved by using EDA or DXM. Conclusion Pretreatment with EDA has protective effects on lung injury resulted from spesis. EDA attenuates acute lung injury likely by means of minimizing oxidative stress and inhibiting expression of proinflammatory cytokines. The combined use of EDA and DXM may be more beneficial than the use of a single agent.